Skip to main content

Navigation group

Type at least 3 characters
15 articles

Articles

Brief Research Report

Published on 04 Mar 2022

Liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes. A Post Hoc Analysis of the LIRAFLAME Randomized Placebo-Controlled Trial

in Diabetes Cardiovascular Complications

  • Asger Wretlind
  • Emilie Hein Zobel
  • Andressa de Zawadzki
  • Rasmus Sejersten Ripa
  • Viktor Rotbain Curovic
  • Bernt Johan von Scholten
  • Ismo Matias Mattila
  • Tine Willum Hansen
  • Andreas Kjær
  • Henrik Vestergaard
Liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes. A Post Hoc Analysis of the LIRAFLAME Randomized Placebo-Controlled Trial
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2022.856485
  • 2,436 views
  • 1 citation

Original Research

Published on 09 Feb 2022

Prevalence of Cardiometabolic Syndrome and its Association With Body Shape Index and A Body Roundness Index Among Type 2 Diabetes Mellitus Patients: A Hospital-Based Cross-Sectional Study in a Ghanaian Population

in Diabetes Cardiovascular Complications

  • Enoch Odame Anto
  • Joseph Frimpong
  • Wina Ivy Ofori Boadu
  • Valentine Christian Kodzo Tsatsu Tamakloe
  • Charity Hughes
  • Benjamin Acquah
  • Emmanuel Acheampong
  • Evans Adu Asamoah
  • Stephen Opoku
  • Michael Appiah
Prevalence of Cardiometabolic Syndrome and its Association With Body Shape Index and A Body Roundness Index Among Type 2 Diabetes Mellitus Patients: A Hospital-Based Cross-Sectional Study in a Ghanaian Population
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2021.807201
  • 4,580 views
  • 9 citations